HOME >> MEDICINE >> NEWS
New 'combination therapy' improves survival for malignant melanoma patients

PITTSBURGH, MAY 30 -- Researchers at the University of Pittsburgh Cancer Institute announced that an immunomodulating agent, histamine dihydrochloride (Maxamine), used in combination with lower doses of interleukin-2 (IL-2), improved survival for stage-IV malignant melanoma patients compared with those treated with the same doses of IL-2 alone. The Phase III, multi-center study included 305 patients with this most deadly and serious form of skin cancer, randomized to receive either the histamine/IL-2 combination or IL-2 alone. The results of the study will be presented for the first time at the Perspectives in Melanoma meeting in Pittsburgh, June 1-2.

The combination therapy improved overall survival, increased survival rates at 12, 18 and 24 months, and improved time-to-disease-progression over treatment with IL-2 alone. Improvement in survival was statistically significant in patients having metastases of their melanoma to the liver, a patient population that historically has had a very poor prognosis.

Preliminary results also indicated that treatment with histamine dihydrochloride and IL-2 was safe and well-tolerated and had substantially less toxicity than the high-dose regimens under which IL-2 was originally approved. The tolerability of the histamine/IL-2 combination therapy allowed these advanced-stage malignant melanoma patients to take this treatment at home.

"The patients in this study represented a group with factors that are indicative of a poor prognosis for survival, including liver metastases," explained Sanjiv S. Agarwala, M.D., lead-enrolling investigator for the study and associate medical director of the Melanoma Center at the University of Pittsburgh Cancer Institute. "This is the first well-controlled, multi-center Phase III trial to show a significant increase in survival among patients with advanced metastatic melanoma."

Treatment of Malignant Melanoma
Malignant melanoma is one of the most rapidly increasing cance
'"/>

Contact: Heather Szafranski
szafranskihl@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
29-May-2000


Page: 1 2 3

Related medicine news :

1. Saint Louis University researcher: Pet therapy works
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
4. New substance that improves the photodetection of bladder cancer gains market approval
5. Most advanced CT scanner improves imaging of heart, avoids need for surgical inspection
6. Columbia study finds hemophilia therapy dramatically improves outcomes for bleeding stroke
7. New test improves detection of bladder cancer
8. Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer
9. Care of rural stroke patients improves with telephone support
10. Acupuncture relieves pain and improves function in knee osteoarthritis
11. Daily social/physical activity improves sleep and cognition in the elderly

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 10, 2020 , ... 3Lions Publishing, ... Business Partner Vetting (BPV) Portal . Expresso® 3.0 contains a Portal where ... more manually mailing, tracking, and performing other administrative tasks that amount to ...
(Date:7/7/2020)... ATLANTA (PRWEB) , ... July 07, 2020 , ... ... offer clients a new way to improve their scalp health. It is now possible ... By adding this treatment process to his practice, Dr. DeJoseph is able to provide ...
(Date:7/7/2020)... ... July 07, 2020 , ... ... or two head design to efficiently sanitize large surfaces is now available in ... available to support sales in that region. , In this era of worldwide ...
(Date:7/4/2020)... ... 2020 , ... Houston Life coach, Rashad Garrett, has thrown a lifeline to ... of his new app, Faith Of A Mustard Seed (FOAMS). , The global pandemic ... issues. In fact, a Federal Agency emergency helpline dedicated to helping people in emotional ...
(Date:7/2/2020)... ... , ... Temprian, a spinoff from Northwestern University, has a ... is vitiligo. Vitiligo patients develop progressive depigmentation of the skin. There is no ... prevalent in all ethnic groups, it is most visible and impactful in people ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... ... July 02, 2020 , ... Gulf ... to announce its donation of more than $190,000 in personal protective equipment (PPE) ... Human Services. As extreme medical shortages continue to plague the nation’s communities and ...
(Date:7/1/2020)... ... July 01, 2020 , ... Stratodesk ... NoTouch OS is available on NComputing devices. Thanks to fantastic new growth and ... have formed a new partnership that will make the full Stratodesk NoTouch OS ...
(Date:6/25/2020)... ... 25, 2020 , ... R3 Medical Training announced today it is now enrolling ... locations. The first course is August 6-7, 2020 in San Diego and the second ... a Virtual Live Stream option. , The two day agenda for each course is ...
Breaking Medicine Technology:
Cached News: